BNTX - BioNTech SE - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

BNTX is currently covered by 15 analysts with an average price target of $119.8. This is a potential upside of $30.49 (34.14%) from yesterday's end of day stock price of $89.31.

BioNTech SE's activity chart (see below) currently has 68 price targets and 127 ratings on display. The stock rating distribution of BNTX is 52.7% BUY, 45.95% HOLD and 1.35% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.86% with an average time for these price targets to be met of 50.56 days.

Highest price target for BNTX is $203, Lowest price target is $99, average price target is $119.8.

Most recent stock forecast was given by ELIANA MERLE from UBS on 27-Mar-2024. First documented stock forecast 04-Nov-2019.

Currently out of the existing stock ratings of BNTX, 39 are a BUY (52.7%), 34 are a HOLD (45.95%), 1 are a SELL (1.35%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

101

$11.69 (13.09%)

153

16 days ago

3/5 (60%)

$8.03 (8.64%)

17

Hold

100

$10.69 (11.97%)

120

1 months 15 days ago

4/9 (44.44%)

$8.57 (9.37%)

77

Buy

107

$17.69 (19.81%)

133

2 months 20 days ago

2/8 (25%)

$6.71 (6.69%)

27

Buy

107

$17.69 (19.81%)

133

2 months 20 days ago

3/19 (15.79%)

$6.71 (6.69%)

5

Sell

99

$9.69 (10.85%)

128

4 months 11 days ago

4/4 (100%)

$-0.4 (-0.40%)

35

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BNTX (BioNTech SE) average time for price targets to be met?

On average it took 50.56 days on average for the stock forecasts to be realized with a an average price target met ratio 55.86

Which analyst has the current highest performing score on BNTX (BioNTech SE) with a proven track record?

ELIANA MERLE

Which analyst has the most public recommendations on BNTX (BioNTech SE)?

Eliana Merle works at UBS and has 4 price targets and 3 ratings on BNTX

Which analyst is the currently most bullish on BNTX (BioNTech SE)?

Olga Smolentseva with highest potential upside - $342.36

Which analyst is the currently most reserved on BNTX (BioNTech SE)?

Jessica Fye with lowest potential downside - $9.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?